1GA
GILD icon

1st Global Advisors’s Gilead Sciences GILD Stock Holding History

1st Global Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-5,169
Closed -$431K – 535
2016
Q2 		$431K Sell
5,169
-519
-9% -$46.1K 0.06% 271
2016
Q1 		$523K Buy
5,688
+1,746
+44% +$157K 0.07% 243
2015
Q4 		$399K Sell
3,942
-580
-13% -$60.4K 0.06% 247
2015
Q3 		$444K Buy
4,522
+19
+0.4% +$2.11K 0.07% 219
2015
Q2 		$857 Buy
4,503
+412
+10% +$45K 0.13% 112
2015
Q1 		$401K Sell
4,091
-27
-0.7% -$2.74K 0.06% 258
2014
Q4 		$388K Buy
4,118
+958
+30% +$99.1K 0.06% 257
2014
Q3 		$336K Buy
+3,160
New +$309K 0.05% 280

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

1st Global Advisors's GILD Position: Q3 2016 in Review

1st Global Advisors sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 5,169 shares — an estimated $431K sold.

1st Global Advisors first reported a position in GILD in Q3 2014 and held it in 8 quarters. The position peaked at $523K in Q1 2016. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • 1st Global Advisors reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • 1st Global Advisors sold 5,169 Gilead Sciences shares in Q3 2016, an estimated $431K.
  • 1st Global Advisors first reported a position in Gilead Sciences in Q3 2014 and held it in 8 quarters.
  • 1st Global Advisors's Gilead Sciences position peaked at $523K in Q1 2016.
  • 1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on 1st Global Advisors's 13F filing for Q3 2016, filed 20 Oct 2016.